XXH-70997-89611
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 074 / NJ
- Registered
- 2022-07-01
- Relationship
- Child or adolescent in my care
- Guardian
- RJB-13627-80746
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-30
Dose 1 — Pfizer-BioNTech
-
2022-07-01
Registered in v-safe
- 2022-07-01
- 2022-07-02
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-06
- 2022-07-07
- 2022-07-14
- 2022-07-21
-
2022-07-26
Dose 2 — Pfizer-BioNTech
- 2022-07-27
- 2022-07-28
-
2022-07-29
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Dysphonia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: HoarsenessMedDRA releases: 2024-11 · check-in free text available
-
2022-07-29
Report sent to call center — days 1–6 daily, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-30
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Dysphonia — Feeling: FairFree text: HoarsenessMedDRA releases: 2024-11 · check-in free text available
- 2022-08-01
-
2022-08-01
Call successfulParticipant prefers to complete VAERS report online
- 2022-08-16
- 2022-08-23
- 2022-08-30
- 2022-09-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-30 | Pfizer-BioNTech | No |
| 2 | 2022-07-26 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Hoarseness
Systemic reaction (other): Hoarseness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dysphonia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release